• 1. Department of Dermatology, the First Hospital of China Medical University, Shenyang 110001, China;2. Department of Oncology, the Fourth Hospital of China Medical University, Shenyang 110001, China;
CHEN HongDuo, Email: chenhd@cae.cn
Export PDF Favorites Scan Get Citation

Objective  To clarify the correlation of p53 codon 72 polymorphism in peripheral blood with keloid susceptibility in Chinese population.
Methods  All the literatures of case-control research on the correlation between p53 codon 72 polymorphism in peripheral blood and keloid in Chinese population were searched in PubMed, EBSCO, CNKI, CBM, and WanFang Data from their establishment to August 2010. Meta-analyses were performed to detect whether there were differences between the keloid group and the control group about the distribution of genotypes of p53 codon 72 in peripheral blood, such as, Pro/Pro vs. Arg/Arg, Pro/Pro vs. Pro/Arg, and alleles Pro vs. Arg.
Results  Five studies involving 328 keloid patients and 420 patients in the control group were included. The results of meta-analyses showed that the population having the genotype Pro/Pro presented no increased keloid risk compared to that with the genotypes Arg/Arg (OR=2.17, 95%CI 0.86 to 5.47) or Pro/Arg (OR=1.90, 95%CI 0.92 to 3.93), while the allele Pro showed significant association with increased keloid risk compared to the allele Arg (OR=1.86, 95%CI 1.03 to 3.35).
Conclusion  The allele Pro of p53 codon 72 in peripheral blood of Chinese population is significantly associated with increased keloid risk.

Citation: WU Yan,LIU Jiali,CHEN Jing,SUN Yan,LI Yuanhong,GAO XingHua,CHEN HongDuo. Correlation between p53 Codon 72 Polymorphism in Peripheral Blood and Keloid in Chinese Population: A Meta-analysis. Chinese Journal of Evidence-Based Medicine, 2011, 11(6): 651-654. doi: 10.7507/1672-2531.20110115 Copy

  • Previous Article

    Exploration Study on the Effectiveness of Problem-Based Learning in Clinical Skill Training
  • Next Article

    Diagnosis Value of 18FDG-PET/CT and 99Tcm-MDP Bone Scan in Bone Metastases of Tumors: A Meta-analysis